Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-01-26

FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (QUALLENT PHARMACEUTICALS HEALTH LLC)

View source ↗

Summary

FDA approved the original application for emtricitabine and tenofovir disoproxil fumarate as a generic product, manufactured by Quallent Pharmaceuticals Health …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emtricitabine and Tenofovir Disoproxil Fumarate (emtricitabine and tenofovir disoproxil fumarate)

Snippet

ORIG AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)